Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018
Get Alerts VCYT Hot Sheet
Join SI Premium – FREE
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that it will report its fourth quarter and full-year 2017 financial results after the close of market on Tuesday, February 27, 2018. Following the announcement, Veracyte will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The call may be accessed as follows:
Veracyte Fourth Quarter and Full-Year 2017 Conference Call, February 27, 2018 at 4:30 p.m. ET | |
Website: | |
Dial-in number (U.S.): |
(855) 541-0980 |
International number: |
(970) 315-0440 |
Conference ID: |
6179798 |
The webcast replay will be available on the company's website approximately two hours following completion of the call and archived on the company's website.
About Veracyte
Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics company that is providing trustworthy and actionable answers that fundamentally improve patient care when current diagnostic tests are uncertain. The company's products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary. Since its founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).
Veracyte, Afirma, Percepta, Envisia, the Veracyte logo, and the Afirma logo are trademarks of Veracyte, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180212005185/en/
Media:
Tracy Morris, 650-380-4413
[email protected]
or
Investors:
Keith
Kennedy, 650-243-6357
Chief Financial Officer
[email protected]
Source: Veracyte
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Mohawk Industries (MHK) Tops Q1 EPS by 19c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!